Position in RLAY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$8,566,728
+$4,010,932 QoQ
Shares Held
457,869
0.0% QoQ
Ownership
0.209%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#63
of 254 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BESSEMER GROUP INC holds $406,568,683 across 93 Biotechnology names. RLAY ranks #5 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
267,779 | $248,437,315 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
141,449 | $44,708,085 | |
| 3 | MAZE |
Maze Therapeutics, Inc.
|
481,790 | $14,376,613 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
354,206 | $11,072,479 | |
| 5 | RLAY |
Relay Therapeutics, Inc.
This page
|
457,869 | $8,566,728 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
20,285 | $7,539,324 | |
| 7 | NRIX |
Nurix Therapeutics, Inc.
|
306,003 | $7,423,632 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
132,555 | $7,280,868 |
All Filings in RLAY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,566,728 | 457,869 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $4,555,796 | 457,869 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $3,873,571 | 457,869 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $3,050,896 | 584,463 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $2,022,473 | 584,530 | Shares | Defined | 2025-08-01 | |
| 2025-03-31 | $1,531,468 | 584,530 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $2,407,987 | 584,463 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,139,201 | 584,633 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,810,698 | 584,463 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,851,042 | 584,463 | Shares | Defined | 2024-08-13 | |
| 2023-12-31 | $6,434,937 | 584,463 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $4,915,333 | 584,463 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,340,855 | 584,463 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $9,626,105 | 584,463 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $8,731,877 | 584,463 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $13,074,437 | 584,463 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $9,789,755 | 584,463 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $17,492,977 | 584,463 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $17,948,858 | 584,463 | Shares | Defined | 2022-01-27 | |
| 2021-09-30 | $18,428,118 | 584,463 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $21,385,501 | 584,463 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $20,204,885 | 584,463 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $22,073,513 | 531,124 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $22,620,571 | 531,124 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||